Development of a technology platform for the discovery of new industrial biocatalysts from marine bacterial diversity.
PONS: Patient-Derived Neurons as a Novel Test System for Schizophrenia Drug Development
New Antifungals in preparation for clinical development against fungal infections
Integrated Drug Discovery Pipeline for Next Generation Aptamers
Personalized treatment regimen decision support tool based on tumor biology for improved cancer care
Canine Antivascular Drugs Against Cancer
Human stem cell cardiomyocyte assays and screening platforms for predicting cardiac safety risk
A new therapeutic approach for severe bleeding
Development of a new platform technology for efficient, fast and cost-effective antibody generation.
New class of HIV inhibitors to overcome resistance to current drugs and improvement of a mouse model